AORT:NYSE
Artivion Inc
US$21,26
arrow_upward
+0,24%(+0,050) 1D
US$21,67
arrow_upward
+1,93% (+0,41)bedtimeAfter hours
Closed: 9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 04 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AORT...
Open
US$21,15
High
US$21,60
Low
US$20,21
Mkt. cap
1,04 ຕື້
Avg. vol.
602,31 ພັນ
Volume
343,50 ພັນ
52-wk high
US$48,25
52-wk low
US$19,16
EPS
US$-0,07
Beta
1,23
Shares outstanding
48,76 ລ້ານ
No. of employees
2 ພັນ
Open
US$21,15
High
US$21,60
Low
US$20,21
Mkt. cap
1,04 ຕື້
Avg. vol.
602,31 ພັນ
Volume
343,50 ພັນ
52-wk high
US$48,25
52-wk low
US$19,16
EPS
US$-0,07
Beta
1,23
Shares outstanding
48,76 ລ້ານ
No. of employees
2 ພັນ
News stories
From web sources and news partners
Stock Traders Daily
·
11 ຊົ່ວໂມງກ່ອນ
Why (AORT) Price Action Is Critical for Tactical Trading
StockStory
·
2 ມື້ກ່ອນ
1 Small-Cap Stock with Exciting Potential and 2 We Turn Down
Profile
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive. Wikipedia
About Artivion Inc
CEOJames Patrick Mackin
Employees1,8 ພັນ
Founded1984
HeadquartersKennesaw, Georgia, ສະຫະລັດ
SectorMedical device
Websiteartivion.com